2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide
TL;DR: 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide (CAS 515120-71-5) is a chemical compound with molecular formula C19H17Br2N3O and molecular weight 460.97 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
2,2-dibromo-1-methyl-N-[(E)-(9-methylcarbazol-3-yl)methylideneamino]cyclopropane-1-carboxamide
Also Known As: 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide, 2,2-dibromo-1-methyl-N'-[(E)-(9-methyl-9H-carbazol-3-yl)methylidene]cyclopropanecarbohydrazide, 2,2-dibromo-1-methyl-N-[(E)-(9-methylcarbazol-3-yl)methylideneamino]cyclopropane-1-carboxamide, N-[(1E)-2-(9-methylcarbazol-3-yl)-1-azavinyl](2,2-dibromo-1-methylcyclopropyl) carboxamide
| Molecular Formula | C19H17Br2N3O |
|---|---|
| Molecular Weight | 460.97 g/mol |
| LogP | 4.6777 |
| Topological Polar Surface Area | 46.39 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 2 |
| Rotatable Bonds | 3 |
| Exact Mass | 460.97385 |
| Heavy Atoms | 25 |
| Complexity | 1037.7526 |
Chemical Identifiers
| CAS Number | 515120-71-5 |
|---|---|
| SMILES | CC1(CC1(Br)Br)C(=O)N/N=C/C2=CC3=C(C=C2)N(C4=CC=CC=C43)C |
Product Overview
2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide (CAS 515120-71-5), with molecular formula C19H17Br2N3O and molecular weight 460.97 g/mol. IUPAC: 2,2-dibromo-1-methyl-N-[(E)-(9-methylcarbazol-3-yl)methylideneamino]cyclopropane-1-carboxamide.
Chemical Property Profile of 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide
Property Insights of 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide
The XLogP value of 4.6777 indicates that 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 46.39 Ų, 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide has 1 hydrogen bond donor(s) and 2 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide?
The CAS number of 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide is 515120-71-5.
What is the molecular formula of 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide?
The molecular formula of 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide is C19H17Br2N3O.
What is the molecular weight of 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide?
The molecular weight of 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide is 460.97 g/mol.
Where can I buy 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide?
You can request a quote for 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide?
Yes, KEHONG BIO provides custom synthesis services for 2,2-dibromo-1-methyl-N'-[(9-methyl-9H-carbazol-3-yl)methylene]cyclopropanecarbohydrazide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.